Fluicell
0.058
SEK
+8.58 %
FLUI
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
4 following
+8.58%
-16.38%
-37.15%
-32.95%
-60.4%
-69.59%
-98.87%
-96.89%
-98.16%
www.fluicell.com/investors
Fluicell is a biotechnology company. The company conducts research and development in processing the composition of cells in the development of new pharmaceuticals. The company has developed a product portfolio consisting of patented research instruments, which are used to study, analyze and finally process cells. In addition, there is expertise in 2D / 3D printing. Fluicell was founded in 2012 and is headquartered in Gothenburg.
Revenue
3.34M
EBIT %
-804.79 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
FLUI
Daily low / high price
0.051 / 0.059
SEK
Market cap
27.98M SEK
Turnover
83.92K SEK
Volume
1.5M
Financial calendar
Extraordinary general meeting
2024-12-10
Annual report
2025-02-21
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Avanza Pension | 8.2 % | 8.2 % |
| Nordnet Pensionsförsäkring AB | 4.0 % | 4.0 % |
| Viola Vitalis AB | 3.8 % | 3.8 % |
| Adamsson, Sten | 2.1 % | 2.1 % |
| Josefsson, Hans | 1.4 % | 1.4 % |
| Frisk, Niklas | 1.2 % | 1.2 % |
| Arctic Securities AS | 0.9 % | 0.9 % |
| Trofast Mikael | 0.9 % | 0.9 % |
ShowingAll content types
Rättelse: Fluicell offentliggör delårsrapport för det tredje kvartalet och de första nio månaderna av 2024
Fluicell offentliggör delårsrapport för det tredje kvartalet och de första nio månaderna av 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools